Read what InspireMD management has to say about the company's voluntary recall of its CGuard Prime 135 cm carotid stent ...

Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting ...

Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth ...

InspireMD (Nasdaq:NSPR) announced today that, in consultation with the FDA, it recalled its CGuard Prime 135 cm carotid stent ...

Clinical experience with Terumo’s Roadsaver™ carotid artery stent system. Edvard Skripochnik, MD Chief, Vascular and ...

Cardiac infections after heart stent procedures are rare but serious, with mortality rates up to 40 percent and symptoms appearing days to weeks later.

A sirolimus eluting balloon performs similarly to a usual care strategy for repeat coronary in stent restenosis at 1 year, ...

TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.

Recent developments of interest in cardiovascular medicine ...

A new report published Tuesday found over one in five coronary stents placed between 2019 and 2021 were unnecessary, costing Medicare $800 million a year and putting patients at risk of complications ...

We are grateful for this Breakthrough Device Designation from the FDA, recognizing that the patients we serve cannot ...